Eli Lilly in new $2.4
Photo: Darron Cummings AP/TT

Eli Lilly in new $2.4 billion deal buys Orna Therapeutics

The American pharmaceutical group Eli Lilly, a major maker of weight-loss drugs, has agreed to acquire the biotechnology company Orna Therapeutics. The deal is worth up to $2.4 billion (approximately SEK 22 billion).

Advertisement

Orna develops treatments that cause the patient's body to generate its own cell therapy against underlying diseases.

Eli Lilly, which is battling Denmark's Novo Nordisk for dominance in the lucrative global market for diet pills, is paying cash. The price of Orna will ultimately be determined by whether the company achieves certain development milestones.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All